FSD Pharma Inc
CNSX:HUGE
Cash Flow Statement
Cash Flow Statement
FSD Pharma Inc
| Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||||
| Net Income |
(7)
|
(9)
|
(5)
|
(17)
|
(20)
|
(34)
|
(51)
|
(39)
|
(51)
|
(37)
|
(38)
|
(28)
|
(27)
|
(39)
|
(30)
|
(34)
|
(30)
|
(25)
|
(27)
|
(27)
|
(31)
|
(29)
|
(23)
|
(18)
|
(10)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
2
|
6
|
4
|
3
|
2
|
3
|
4
|
5
|
6
|
7
|
5
|
5
|
5
|
4
|
3
|
1
|
|
| Other Non-Cash Items |
4
|
5
|
(8)
|
3
|
(0)
|
11
|
29
|
24
|
34
|
20
|
20
|
5
|
2
|
8
|
3
|
6
|
3
|
0
|
1
|
1
|
6
|
7
|
4
|
3
|
(0)
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
1
|
(1)
|
(1)
|
(0)
|
(1)
|
(3)
|
2
|
(1)
|
(4)
|
1
|
(2)
|
1
|
4
|
5
|
3
|
3
|
3
|
(2)
|
(5)
|
(7)
|
(7)
|
(5)
|
(1)
|
2
|
1
|
|
| Cash from Operating Activities |
(2)
N/A
|
(5)
-142%
|
(15)
-222%
|
(14)
+4%
|
(21)
-50%
|
(26)
-23%
|
(18)
+28%
|
(14)
+26%
|
(18)
-31%
|
(12)
+30%
|
(15)
-24%
|
(19)
-23%
|
(17)
+10%
|
(22)
-27%
|
(21)
+6%
|
(21)
0%
|
(20)
+2%
|
(23)
-14%
|
(26)
-13%
|
(28)
-9%
|
(28)
+1%
|
(22)
+21%
|
(16)
+26%
|
(11)
+34%
|
(8)
+26%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||||
| Capital Expenditures |
(10)
|
(11)
|
(11)
|
(3)
|
0
|
(1)
|
0
|
(1)
|
0
|
(1)
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Other Items |
0
|
(1)
|
0
|
(4)
|
(0)
|
1
|
(0)
|
0
|
9
|
7
|
8
|
7
|
(1)
|
0
|
0
|
1
|
1
|
14
|
13
|
12
|
12
|
(0)
|
(1)
|
(0)
|
(0)
|
|
| Cash from Investing Activities |
(10)
N/A
|
(12)
-12%
|
(17)
-41%
|
(7)
+55%
|
(8)
-3%
|
(6)
+21%
|
(1)
+82%
|
(0)
+79%
|
8
N/A
|
7
-16%
|
7
+4%
|
7
-6%
|
(2)
N/A
|
(0)
+79%
|
(0)
+63%
|
0
N/A
|
1
+146%
|
13
+1 920%
|
13
-6%
|
12
-4%
|
12
+1%
|
(0)
N/A
|
(1)
-35%
|
(0)
+59%
|
(0)
-8%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||||
| Net Issuance of Common Stock |
17
|
49
|
66
|
36
|
46
|
14
|
(3)
|
4
|
4
|
11
|
21
|
25
|
64
|
57
|
46
|
38
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Other |
0
|
0
|
(1)
|
(3)
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
15
N/A
|
48
+211%
|
65
+35%
|
34
-48%
|
42
+26%
|
10
-77%
|
(7)
N/A
|
4
N/A
|
4
-5%
|
11
+179%
|
20
+92%
|
24
+19%
|
62
+158%
|
55
-11%
|
46
-18%
|
38
-16%
|
(2)
N/A
|
(2)
-14%
|
(2)
-14%
|
(2)
-2%
|
(4)
-73%
|
(3)
+6%
|
(3)
+6%
|
(3)
+1%
|
0
N/A
|
|
| Change in Cash | ||||||||||||||||||||||||||
| Net Change in Cash |
3
N/A
|
31
+935%
|
34
+7%
|
12
-63%
|
14
+14%
|
(22)
N/A
|
(27)
-21%
|
(10)
+63%
|
(6)
+38%
|
5
N/A
|
12
+145%
|
12
-2%
|
43
+276%
|
33
-24%
|
25
-25%
|
18
-29%
|
(21)
N/A
|
(12)
+46%
|
(16)
-34%
|
(18)
-17%
|
(19)
-6%
|
(26)
-34%
|
(20)
+22%
|
(14)
+29%
|
(8)
+45%
|
|
| Free Cash Flow | ||||||||||||||||||||||||||
| Free Cash Flow |
(12)
N/A
|
(15)
-22%
|
(25)
-69%
|
(17)
+33%
|
(21)
-23%
|
(27)
-29%
|
(18)
+32%
|
(14)
+22%
|
(18)
-25%
|
(13)
+26%
|
(15)
-17%
|
(19)
-23%
|
(18)
+7%
|
(22)
-26%
|
(21)
+6%
|
(21)
0%
|
(21)
+3%
|
(23)
-14%
|
(26)
-13%
|
(29)
-9%
|
(28)
+2%
|
(22)
+21%
|
(16)
+27%
|
(11)
+34%
|
(8)
+26%
|
|